41 results on '"Linardos, Giulia"'
Search Results
2. Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study
3. Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years
4. B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
5. Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old
6. Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy
7. Presence of neutralizing SARS‐CoV‐2 antibodies in asymptomatic population of N'Djamena, Chad
8. Cytokine expression patterns in hospitalized children with Bordetella pertussis, Rhinovirus or co-infection
9. School in Italy: a safe place for children and adolescents
10. Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients
11. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic.
12. Acute Hepatitis of Unknown Origin in Children: Analysis of 17 Cases Admitted to the Bambino Gesù Children's Hospital in Rome.
13. The COVID-19 wave was already here: High seroprevalence of SARS-CoV-2 antibodies among staff and students in a Cameroon University
14. High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad
15. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
16. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
17. B Cell Immunity and Vaccine Induced Antibody Protection Reveal the Inefficacy of Current Vaccination Schedule in Infants with Perinatal HIV Infection in Mozambique, Africa
18. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020
19. Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection
20. SARS-COV2 Seroprevalence in a Cohort of Perinatally HIV Infected Children and Young Adults From May to December 2020 in Italy
21. High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad.
22. Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
23. Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease
24. The impact of pertussis in infants: insights from a hospital-based enhanced surveillance system, Lazio region, Italy, 2016 to 2019
25. Highly-specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA
26. Sars-Cov2 Not Detected in a Pediatric Population With Acute Respiratory Infection in Primary Care in Central and Southern Italy From November 2019 to Early March 2020
27. VIROLOGICAL AND IMMUNOLOGICAL FEATURES OF SARS-COV-2 INFECTED CHILDREN WITH DISTINCT SYMPTOMATOLOGY
28. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
29. Persistent B-Cell Memory After SARS-CoV-2 Vaccination is Functional During Breakthrough Infections
30. Waning of Serum Antibodies, But Increase of Protective B-Cell Memory Nine Months After BNT162b2 Vaccination
31. Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital
32. A data driven clinical algorithm for differential diagnosis of pertussis and other respiratory infections in infants
33. Virological and Immunological Features of SARS-CoV-2 Infected Children Developing Specific and Neutralizing Antibodies
34. Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
35. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
36. Virological and immunological features of SARS‐COV‐2 infected children with distinct symptomatology.
37. Colistin-resistant microorganisms and cystic fibrosis: microbiological surveillance in an Italian Children’s Hospital
38. Breastfeeding and Respiratory Infections in the First 6 Months of Life: A Case Control Study
39. Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.
40. Prevalence of Epstein-Barr Virus infection in a cohort of onco-hematologic paediatric patients.
41. Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.